American Well Corp

AMWL.US
Healthcare · Health Information Services
11.14
+0.09 (+0.81%)
USD · NYSE

Company Information

Company Name
American Well Corp
Sector
Healthcare
Industry
Health Information Services
Exchange
NYSE
ISIN: US03044L1052
CIK: 0001393584
CUSIP: 03044L105
Currency: USD
Full Time Employees: 562
Phone: 617 204 3500
Fiscal Year End: December
IPO Date: Sep 17, 2020
Description:

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Address:

75 State Street, Boston, MA, United States, 02109

People

Directors & Officers

Name Title Year Born
Dr. Ido Schoenberg M.D. Chairman & CEO 1965
Mr. Mark J. Hirschhorn CPA Executive VP, COO & CFO 1965
Mr. Dan Zamansky Chief Product & Technology Officer 1984
Mr. Paul Francis McNeice Vice President of Accounting 1977
Ms. Sue Dooley Head of Investor Relations NA
Anna Nesterova Head of Legal & Deputy General Counsel NA
Mr. Michael Miller Senior Vice President & Chief Sales Officer NA
Ms. Phyllis I. Gotlib President of Amwell International 1958
Dr. Cynthia Horner FAAFP, M.D. Chief Medical Officer & President of Amwell Medical Group NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 01, 2026 Paul Francis Mcneice N/A Sale 383.00 $5.30 $2.03K
Apr 01, 2026 Phyllis Gotlib N/A Sale 3.71K $5.30 $19.64K
Apr 01, 2026 Dmitry Zamansky N/A Sale 5.58K $5.30 $29.55K
Jan 02, 2026 Dmitry Zamansky N/A Sale 6.24K $4.85 $30.28K
Jan 02, 2026 Paul Francis Mcneice N/A Sale 384.00 $4.85 $1.86K
Jan 02, 2026 Phyllis Gotlib N/A Sale 3.71K $4.85 $17.98K
Dec 18, 2025 Deborah C Jackson N/A Sale 612.00 $4.71 $2.88K
Dec 01, 2025 Paul Francis Mcneice N/A Sale 113.00 $4.06 $458.78
Dec 01, 2025 Phyllis Gotlib N/A Sale 3.57K $4.06 $14.51K
Oct 01, 2025 Phyllis Gotlib N/A Sale 4.96K $6.11 $30.30K
Oct 01, 2025 Paul Francis Mcneice N/A Sale 332.00 $6.11 $2.03K
Sep 15, 2025 Deborah C Jackson N/A Sale 4.53K $6.56 $29.72K
Sep 03, 2025 Dmitry Zamansky N/A Sale 25.61K $6.77 $173.35K
Sep 02, 2025 Deborah C Jackson N/A Sale 4.53K $6.79 $30.77K
Sep 02, 2025 Paul Francis Mcneice N/A Sale 113.00 $6.78 $766.14
Sep 02, 2025 Phyllis Gotlib N/A Sale 4.78K $6.78 $32.42K
Aug 19, 2025 Deborah C Jackson N/A Sale 4.53K $7.10 $32.17K
Jul 01, 2025 Paul Francis Mcneice N/A Sale 331.00 $8.63 $2.86K
Jul 01, 2025 Phyllis Gotlib N/A Sale 4.96K $8.63 $42.79K
Jun 02, 2025 Paul Francis Mcneice N/A Sale 113.00 $6.61 $746.93

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Morgan Stanley - Brokerage Accounts 1.16M Mar 31, 2026 6.92% $0.00 -1.53%
RIMA MANAGEMENT, LLC 1.14M Mar 31, 2026 6.80% $0.20 213.34%
Cable Car Capital LLC 1.00M Mar 31, 2026 6.00% $1.82 81.20%
Vanguard Group Inc 612.61K Dec 31, 2025 3.67% $0.00 -5.77%
Vanguard Capital Management, LLC 567.27K Mar 31, 2026 3.40% $0.00 0.00%
Acadian Asset Management LLC 406.62K Mar 31, 2026 2.43% $0.00 0.00%
BlackRock Inc 391.38K Mar 31, 2026 2.34% $0.00 -3.58%
Renaissance Technologies Corp 195.02K Mar 31, 2026 1.17% $0.00 -1.42%
Geode Capital Management, LLC 188.37K Mar 31, 2026 1.13% $0.00 23.33%
Rock Point Advisors, LLC 136.09K Mar 31, 2026 0.81% $0.19 1.87%
Two Sigma Investments LLC 133.01K Mar 31, 2026 0.80% $0.00 22.09%
The Goldman Sachs Group Inc 123.60K Mar 31, 2026 0.74% $0.00 92.79%
Dimensional Fund Advisors, Inc. 89.00K Mar 31, 2026 0.53% $0.00 1.40%
Two Sigma Advisers, LLC 87.65K Dec 31, 2025 0.52% $0.00 103.55%
Vanguard Fiduciary Trust Co 79.93K Mar 31, 2026 0.48% $0.00 0.00%
Monaco Asset Management 68.94K Mar 31, 2026 0.41% $0.07 0.00%
GSA Capital Partners LLP 56.87K Mar 31, 2026 0.34% $0.02 -11.99%
State Street Corp 56.60K Mar 31, 2026 0.34% $0.00 8.22%
Jane Street Group LLC 54.11K Mar 31, 2026 0.32% $0.00 -56.05%
Citadel Advisors Llc 49.29K Mar 31, 2026 0.30% $0.00 -42.85%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 427.29K 2.56% ▲ 3.48% Jun 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 169.38K 1.01% ▲ 5.28% Jun 30, 2026
3 Fidelity Extended Market Index 100.31K 0.60% ▼ 8.77% May 31, 2026
4 Russell Inv US Small Cap Equity Y 69.55K 0.42% ▲ 183.65% Jun 30, 2026
5 BSF Systematic US Eq Abs Ret A2 USD 58.13K 0.35% ▲ 0.00% Dec 31, 2025
6 Dimensional US Small Cap ETF 48.87K 0.29% ▲ 0.00% Jun 30, 2026
7 iShares Micro-Cap ETF 48.62K 0.29% ▲ 0.00% Jun 30, 2026
8 Bridgeway Ultra-Small Company 42.99K 0.26% ▼ 41.10% Mar 31, 2026
9 Russell Investment Small Cap Fund F 36.17K 0.22% ▲ 0.00% Jun 30, 2026
10 Extended Equity Market Fund B 29.54K 0.18% ▲ 0.00% Dec 31, 2025

Financial Highlights

Market Cap: $185.30M
EBITDA: $-46.32M
Book Value: $13.65
Earnings/Share: $-5.45
Profit Margin: -37.02%
Operating Margin: -23.59%
ROA (TTM): -13.43%
ROE (TTM): -31.84%
Revenue (TTM): $237.38M
Revenue/Share (TTM): $14.58
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -17.90%

Valuation Metrics

Enterprise Value: $9.38M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 15.06M
Shares Float: 11.72M
% Insiders: 542.30%
% Institutions: 4,601.40%
Short % Float: 1.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$249.33M
Cost of Goods Sold
adjust
$-116.47M
Gross Profit
subtotal
$132.86M
SG&A
adjust
$-88.05M
R&D
adjust
$-72.86M
Other Operating Expense
adjust
$-77.23M
Operating Income
subtotal
$-105.27M
Other / Non-Operating Items
adjust
$9.57M
Net Income
subtotal
$-95.70M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about AMWL.US!